Drug recall · December 18, 2024
Hylenex recombinant recall
Why: cGMP Deviations: Temperature excursion
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for and marketed by Halozyme, Inc., 12390 El Camino Real San Diego California 92130, Distributed by Antares Pharma, Inc., Ewing, NJ NDC 18657-117-04
- Lots / codes
Serial # 100000831961 100000820688 100000820689 100000820515
- Quantity
- 5 cartons/20 units each carton
- Company
- Mckesson Medical-Surgical Inc. Corporate Office, Richmond, VA
- Distribution
- Virgina
- Initiated
- September 11, 2024 · Voluntary: Firm initiated
- Classified
- December 10, 2024
- Reported
- December 18, 2024
- Ended
- August 20, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hylenex
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.